Is carotid endarterectomy justified in patients with severe chronic renal insufficiency?

E E Rigdon1, N Monajjem, R S Rhodes

  • 1Department of Surgery, University of Mississippi Medical Center, Jackson 39216-4505, USA.

Insights

Patients with severe chronic renal insufficiency (CRI) face significantly higher risks of stroke and death after carotid endarterectomy (CEA). Mild CRI does not increase these risks, suggesting careful patient selection for CEA is crucial.

Area of Science:

  • Vascular Surgery
  • Nephrology
  • Cardiology

Background:

  • Chronic renal insufficiency (CRI) is a common comorbidity.
  • The impact of CRI on adverse events after carotid endarterectomy (CEA) is not fully understood.
  • Associated co-morbidities may further influence surgical outcomes.

Purpose of the Study:

  • To evaluate the effect of chronic renal insufficiency (CRI) on adverse events after CEA.
  • To assess the influence of co-morbid conditions on stroke, cardiac events, and death within 30 days post-CEA.
  • To determine risk factors for adverse outcomes in patients undergoing CEA.

Main Methods:

  • Retrospective analysis of 285 CEAs performed between 1980 and 1994.
  • Patients categorized by renal function: normal, mild CRI (creatinine 1.5-2.9 mg/dl), and severe CRI (creatinine > 2.9 mg/dl).
  • Evaluation of demographic, clinical, and surgical variables for association with adverse events.

Main Results:

  • Severe CRI significantly increased the risk of postoperative stroke (43% vs. 6%) and death (p < 0.001) compared to normal renal function.
  • Mild CRI did not show a significant difference in stroke or death rates compared to normal renal function.
  • Perioperative hypertension was noted in patients with severe CRI who experienced stroke; other factors like age, diabetes, or smoking were not significant risk factors for stroke.

Conclusions:

  • Patients with severe CRI are at significantly higher risk for stroke and death following CEA.
  • CEA in severe CRI patients should be reserved for carefully selected cases with symptomatic disease and acceptable risk factors.
  • Patients with mild CRI can be considered for CEA with the same risk profile as those with normal renal function.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...